Balyasny Asset Management LLC Standard Biotools Inc. Transaction History

Balyasny Asset Management LLC

$61.9 Billion
Q2 2025

A detailed history of Balyasny Asset Management LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 86,005 shares of LAB stock, worth $112,666. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,005

Previous 86,005 -0.0%

Holding current value

$112,666

Previous $92,000 11.96%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.01 - $2.06 $655,488 - $1.34 Million	-648,999 Reduced 88.3%	86,005 $92,000
Q4 2024 Feb 14, 2025	SELL	$1.5 - $2.26 $385,050 - $580,142	-256,700 Reduced 25.88%	735,004 $1.29 Million
Q3 2024 Nov 14, 2024	SELL	$1.42 - $2.35 $9,170 - $15,176	-6,458 Reduced 0.65%	991,704 $1.91 Million
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.92 $6.35 Million - $11.2 Million	-3,846,889 Reduced 79.4%	998,162 $1.77 Million
Q1 2024 May 13, 2024	BUY	$1.87 - $2.78 $4.98 Million - $7.4 Million	2,662,864 Added 122.03%	4,845,051 $13.1 Million
Q4 2023 Feb 14, 2024	SELL	$1.59 - $2.73 $818,091 - $1.4 Million	-514,523 Reduced 19.08%	2,182,187 $4.82 Million
Q3 2023 Nov 14, 2023	BUY	$1.9 - $3.05 $1.13 Million - $1.81 Million	595,020 Added 28.31%	2,696,710 $7.82 Million
Q2 2023 Aug 14, 2023	BUY	$1.47 - $2.56 $3.09 Million - $5.38 Million	2,101,690 New	2,101,690 $4.06 Million
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $1.82 Million - $4.54 Million	1,137,361 New	1,137,361 $1.82 Million
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $1.96 Million - $2.77 Million	-700,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $1.38 Million - $2.34 Million	381,009 Added 119.44%	700,000 $2.74 Million
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $1.75 Million - $2.36 Million	318,991 New	318,991 $2.1 Million
Q2 2018 Aug 14, 2018	SELL	$4.86 - $6.24 $123,871 - $159,045	-25,488 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $82,731 - $114,672	14,388 Added 129.62%	25,488 $149,000
Q4 2017 Feb 14, 2018	BUY	$4.46 - $6.45 $49,506 - $71,595	11,100	11,100 $65,000

Others Institutions Holding LAB

# of Institutions

165

Shares Held

278M

Call Options Held

34.9K

Put Options Held

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $103M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Standard Biotools Inc. Transaction History